SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-18-002721
Filing Date
2018-09-12
Accepted
2018-09-12 17:23:31
Documents
54
Period of Report
2018-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pharmacyte_10q-073118.htm 10-Q 323414
2 CERTIFICATION pharmacyte_10q-ex3101.htm EX-31.1 8490
3 CERTIFICATION pharmacyte_10q-ex3102.htm EX-31.2 8512
4 CERTIFICATION pharmacyte_10q-ex3201.htm EX-32.1 3995
5 CERTIFICATION pharmacyte_10q-ex3202.htm EX-32.2 4163
  Complete submission text file 0001683168-18-002721.txt   2584369

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pmcb-20180731.xml EX-101.INS 466431
7 XBRL SCHEMA FILE pmcb-20180731.xsd EX-101.SCH 29262
8 XBRL CALCULATION FILE pmcb-20180731_cal.xml EX-101.CAL 35199
9 XBRL DEFINITION FILE pmcb-20180731_def.xml EX-101.DEF 140524
10 XBRL LABEL FILE pmcb-20180731_lab.xml EX-101.LAB 222037
11 XBRL PRESENTATION FILE pmcb-20180731_pre.xml EX-101.PRE 200849
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 333-68008 | Film No.: 181067443
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1